<DOC>
	<DOCNO>NCT01967329</DOCNO>
	<brief_summary>The CANHelp Working Group Treatment Trials part comprehensive research program carry Canadian North Helicobacter pylorus ( CANHelp ) Working Group . The treatment component involve series community-specific trial design community input vary specific treatment regimens number treatment arm among study detail .</brief_summary>
	<brief_title>CANHelp Working Group Treatment Trials</brief_title>
	<detailed_description>The CANHelp Working Group collaborative team link University Alberta researcher Canadian northern community leader health official collaborative effort investigate H. pylori infection goal find solution community concern health risk . The research program use community-driven research approach northern community characterize burden disease H. pylorus infection exchange knowledge community member decision maker identify way reduce health risk infection . For participate community , treatment trial aim : 1 . Estimate effectiveness alternate H. pylorus treatment regimen identify optimal regimen local set 2 . Identify factor external treatment regimen influence short- long-term treatment success</detailed_description>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Tetracycline</mesh_term>
	<mesh_term>Bismuth subsalicylate</mesh_term>
	<mesh_term>Bismuth</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Over 15 year age Identified H. pylorus infect positive urea breath test and/or biopsybased evidence H. pylorus infection Allergy amoxicillin , metronidazole clarithromycin Antibiotic therapy within 4 week prior randomization Pregnant breastfeeding Severe cardiorespiratory , pulmonary , endocrine , hepatic renal disease</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>